These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 9347180)

  • 1. Prokinetic therapy in gastroesophageal reflux disease.
    Champion MC
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():55B-65B. PubMed ID: 9347180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical considerations in GERD (gastroesophageal reflux disease) therapy: focus on cisapride.
    Snape WJ
    Am J Manag Care; 1997 May; 3(5):766-71. PubMed ID: 10184748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prokinetic therapy for gastroesophageal reflux disease.
    Robinson M
    Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prokinetic approach to treatment of gastroesophageal reflux disease.
    Achem SR; Robinson M
    Dig Dis; 1998; 16(1):38-46. PubMed ID: 9549035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents.
    McCallum RW
    Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK; Khanderia U
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC; Wolfe MM
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized acute treatment strategies for gastroesophageal reflux disease.
    Reynolds JC
    Scand J Gastroenterol Suppl; 1995; 213():17-24. PubMed ID: 8578239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal reflux in infants and children.
    Jung AD
    Am Fam Physician; 2001 Dec; 64(11):1853-60. PubMed ID: 11764863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current status of gastric prokinetic drugs.
    Schapira M; Henrion J; Heller FR
    Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group.
    Castell DO; Sigmund C; Patterson D; Lambert R; Hasner D; Clyde C; Zeldis JB
    Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal pH assessment of gastroesophageal reflux in 18 patients and the effect of two prokinetic agents: cisapride and metoclopramide.
    Rode H; Stunden RJ; Millar AJ; Cywes S
    J Pediatr Surg; 1987 Oct; 22(10):931-4. PubMed ID: 3681625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.
    Poe RH; Kallay MC
    Chest; 2003 Mar; 123(3):679-84. PubMed ID: 12628862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maintenance therapy of mild form of GERD by H2 receptor antagonists].
    Kurosawa S
    Nihon Rinsho; 2000 Sep; 58(9):1859-64. PubMed ID: 11004816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
    Halter F; Staub P; Hammer B; Guyot J; Miazza BM
    J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile and assessment of GERD pharmacotherapy.
    Maton PN
    Cleve Clin J Med; 2003 Nov; 70 Suppl 5():S51-70. PubMed ID: 14705381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.
    Kahrilas PJ; Howden CW; Hughes N
    Am J Gastroenterol; 2011 Aug; 106(8):1419-25; quiz 1426. PubMed ID: 21537361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.